Pet Safety / Compounds / Clindamycin

Is Clindamycin safe for dogs and cats?

Low risk for pets

Clindamycin is widely used in veterinary medicine for cats and dogs; FDA-approved veterinary formulations exist (Antirobe); used for dental/oral infections, bone infections, skin infections, toxoplasmosis, and neosporosis in dogs. Veterinary dosing (dogs): 11–22 mg/kg every 12–24 hours orally for most indications; dental infections typically 5–11 mg/kg BID. Dental/oral infections: clindamycin's excellent anaerobic coverage and good bone/tissue penetration make it a preferred choice for dental abscesses, periodontal disease, and oral infections in dogs — the most common veterinary indication. CDiff in dogs: C. difficile-associated diarrhea in dogs does occur but is less common and less severe than in humans; Clostridium perfringens-associated diarrhea is more common in dogs treated with clindamycin; diarrhea during or after clindamycin treatment warrants CDiff testing in dogs. Bone/joint infections: clindamycin's lipophilic properties allow excellent penetration into bone, joint, and abscess tissue — a clinical advantage for osteomyelitis and septic arthritis caused by gram-positive and anaerobic organisms. Toxoplasmosis: clindamycin (12.5 mg/kg BID for 4 weeks) is the treatment of choice for toxoplasmosis in dogs and the only approved therapy for ocular toxoplasmosis; specific antitoxoplasmal activity makes it irreplaceable in this indication.

What is clindamycin?

The IUPAC name is (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide.

Also known as: (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide, Chlolincocin, Clinimycin, Clindamicina.

IUPAC name
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
CAS number
18323-44-9
Molecular formula
C18H33ClN2O5S
Molecular weight
425.0 g/mol
SMILES
CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
PubChem CID
446598

Risk for dogs

Low risk

Clindamycin is widely used in veterinary medicine for cats and dogs; FDA-approved veterinary formulations exist (Antirobe); used for dental/oral infections, bone infections, skin infections, toxoplasmosis, and neosporosis in dogs. Veterinary dosing (dogs): 11–22 mg/kg every 12–24 hours orally for most indications; dental infections typically 5–11 mg/kg BID. Dental/oral infections: clindamycin's excellent anaerobic coverage and good bone/tissue penetration make it a preferred choice for dental abscesses, periodontal disease, and oral infections in dogs — the most common veterinary indication. CDiff in dogs: C. difficile-associated diarrhea in dogs does occur but is less common and less severe than in humans; Clostridium perfringens-associated diarrhea is more common in dogs treated with clindamycin; diarrhea during or after clindamycin treatment warrants CDiff testing in dogs. Bone/joint infections: clindamycin's lipophilic properties allow excellent penetration into bone, joint, and abscess tissue — a clinical advantage for osteomyelitis and septic arthritis caused by gram-positive and anaerobic organisms. Toxoplasmosis: clindamycin (12.5 mg/kg BID for 4 weeks) is the treatment of choice for toxoplasmosis in dogs and the only approved therapy for ocular toxoplasmosis; specific antitoxoplasmal activity makes it irreplaceable in this indication.

Regulatory consensus

1 regulatory bodyhas classified Clindamycin.

AgencyYearClassificationNotes
FDA—Approved for serious infections caused by susceptible gram-positive aerobes (MRSA, streptococci) and anaerobic bacteria

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where pets encounter clindamycin

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Clindamycin:

  • Alternative drug class; Non-pharmacological therapy; Lowest effective dose
    Trade-offs: Direct chemical substitution requires verification that the replacement does not introduce new hazards (regrettable substitution). Conduct full hazard assessment of proposed alternative before adoption.
    Relative cost: 1.2-2×

Frequently asked questions

Is clindamycin safe for pets?

Clindamycin is widely used in veterinary medicine for cats and dogs; FDA-approved veterinary formulations exist (Antirobe); used for dental/oral infections, bone infections, skin infections, toxoplasmosis, and neosporosis in dogs. Veterinary dosing (dogs): 11–22 mg/kg every 12–24 hours orally for most indications; dental infections typically 5–11 mg/kg BID. Dental/oral infections: clindamycin's excellent anaerobic coverage and good bone/tissue penetration make it a preferred choice for dental abscesses, periodontal disease, and oral infections in dogs — the most common veterinary indication. CDiff in dogs: C. difficile-associated diarrhea in dogs does occur but is less common and less severe than in humans; Clostridium perfringens-associated diarrhea is more common in dogs treated with clindamycin; diarrhea during or after clindamycin treatment warrants CDiff testing in dogs. Bone/joint infections: clindamycin's lipophilic properties allow excellent penetration into bone, joint, and abscess tissue — a clinical advantage for osteomyelitis and septic arthritis caused by gram-positive and anaerobic organisms. Toxoplasmosis: clindamycin (12.5 mg/kg BID for 4 weeks) is the treatment of choice for toxoplasmosis in dogs and the only approved therapy for ocular toxoplasmosis; specific antitoxoplasmal activity makes it irreplaceable in this indication.

What products contain clindamycin?

Clindamycin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

See Clindamycin in the pets app

Look up products containing clindamycin, compare to alternatives, and explore the full data record.

Open in pets View raw API data

Sources (2)
  1. FDA Prescribing Information: Clindamycin (Cleocin/Antirobe) — lincosamide; highest CDiff risk; topical acne; dental prophylaxis; MRSA; inducible D-test resistance; bone penetration; toxoplasmosis; esophageal ulceration; veterinary dental infections (2023) (2023) — regulatory
  2. WHO AWaRe Classification of Antibiotics — Access/Watch/Reserve categories; stewardship framework; amoxicillin Access category; ciprofloxacin/azithromycin Watch; vancomycin Reserve; resistance drivers; outpatient prescribing guidance (2023) (2023) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →